Kevin Hambly

Business Development
Pharmaceuticals
ALDER Biopharmaceuticals
United States of America

Biography

Head of business development for Catalent Biologics' Redwood Bioscience ADC group, and BD lead for new Biologics technology licensing and acquisitions - Led partnering process for a preclinical anti-CD22 ADC for lymphoma, culminating in an exclusive agreement with Triphase Accelerator Corporation for global development and commercialization under Triphase's collaboration and option agreement with Celgene

Research Interest

Oncology, Business development, Licensing

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America